Canbex Therapeutics hires chief medical officer
March 5, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canbex Therapeutics
UK biotech firm Canbex Therapeutics has appointed former Lilly head Dr Alberto Lledó as its new chief medical officer (CMO). …
NICE U-turn on Pfizer drug Inlyta
March 5, 2014Research and Development, Sales and Marketing Kidney cancer, NHS, NICE, Pfizer, axitinib, inlyta
NICE has recommended that Pfizer’s kidney cancer drug Inlyta should be used for some patients in England, following a similar …
Cobra agrees oncology deal with BioCancell
March 4, 2014Manufacturing and Production, Research and Development BC-821, Cobra, biocancell, oncology
Contract manufacturing organisation Cobra Biologics has signed a deal with specialist oncology biopharma firm BioCancell to manufacture an investigational cancer …
Clinical studies still not being published
March 4, 2014Research and Development, Sales and Marketing ABPI, EMA, alltrials, clinical trials, csr
Half of all trials registered on a US clinical study database are not being published in public journals. This is …
CluePoints appoints three heads
March 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cluepoints, colby, polvent, stephenne
Clinical trial data firm CluePoints has announced three new appointments to its global team. John Colby (pictured) and Elizabeth Polvent join …
Alexion ‘concerned’ over NICE draft
March 4, 2014Sales and Marketing NICE, aHUS, alexia, blood, eculizumab, soliris
Alexion Pharmaceuticals UK has expressed ‘concern’ that NICE has not yet allowed its rare disease treatment Soliris to be formally …
Exploring the Amber™ auto injector
March 4, 2014Manufacturing and Production amber autoinjector, auto injector, shl group
SHL first introduced the Amber™ auto injector utilizing Pushclick™ technology at the PDA (Parental Drug Association) event in Basel, Switzerland …
Print adverts’ prescribing info could be axed
March 3, 2014Medical Communications MHRA, OTC, medicines, prescribing
The UK drugs regulator is proposing new rules that could see pharma update safety information for their medicines online, whilst …
Roche lung cancer drug fails
March 3, 2014Research and Development, Sales and Marketing Cancer, MetMAb, NSCLC, Roche, Tarceva, avastin
An independent data monitoring committee has told Roche to halt a study of its experimental lung cancer drug MetMab due …
Xarelto lift for Bayer
March 3, 2014Manufacturing and Production, Sales and Marketing Bayer, Eylea, Stivarga, Xarelto, blood thinner, xofigo
Bayer Group says sales of its blood thinner Xarelto will be higher than it had predicted, with peak annual sales …
Cello unifies all its health agencies
March 3, 2014Medical Communications Cello, Cello Business Sciences, Insight Research Group, Mash Health Group, MedErgy HealthGroup, The MSI Consultancy
The Cello Group has unified all its health-orientated agencies in order to operate under one umbrella brand called Cello Health. …
GSK submits new Promacta licence
March 3, 2014Sales and Marketing GSK, NICE, Promacta, Revolade, blood, eltrombopag
GlaxoSmithKline is seeking a new licence for its blood disorder drug Promacta in patients with severe aplastic anaemia. Specifically, the …
dna Medical Communications hires MD
March 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dna Medical Communications, neil flash
Neil Flash has joined healthcare agency dna Medical Communications as the managing director for its UK team. Flash joined dna …
Look beyond the screen
March 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, cliinical, data, screening, trials
It makes sense, doesn’t it? You have a drug that’s effective for a certain disease, but no patients. What do …
Insurance firms ‘will not be sold records’
March 3, 2014Sales and Marketing GPs, HSCIC, Hunt, NHS, care data, care.data
The government is to pledge that insurance companies will not be sold patients’ health records via the care.data information sharing …
Government questions innovation uptake by doctors
February 28, 2014Medical Communications, Sales and Marketing ABPI, Hunt, NHS, PPRS, UK, doctors
The government has launched a consultation which aims to establish whether doctors are being held back from using innovative treatments, …
GSK’s Witty loses bonus over China scandal
February 28, 2014Medical Communications, Sales and Marketing China, GSK, Witty, sales, sir andrew
GlaxoSmithKline’s chief executive Sir Andrew Witty received bonuses “lower than they otherwise might have been” last year due to the …
Packer Forbes Communications adds managing director
February 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Packer Forbes, joella webber
Comms agency Packer Forbes Communications is strengthening its leadership team by appointing Joella Webber as managing director. Webber who was …
NICE rejects Alimta
February 28, 2014Sales and Marketing Alimta, Cancer, NHS, NICE, NSCLC, lilly, pemetrexed
Eli Lilly is coming to terms with rejection by NICE after the cost watchdog said it would not recommend Alimta …
Novartis extends trial transparency
February 27, 2014Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency
Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.
Latest content
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
